Gabapentin enacarbil
- Generic Name
- Gabapentin enacarbil
- Brand Names
- Horizant
- Drug Type
- Small Molecule
- Chemical Formula
- C16H27NO6
- CAS Number
- 478296-72-9
- Unique Ingredient Identifier
- 75OCL1SPBQ
Overview
Gabapentin enacarbil is marketed under the name Horizant. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
Background
Gabapentin enacarbil is marketed under the name Horizant. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
Indication
For the treatment of adult Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
Associated Conditions
- Postherpetic Neuralgia
- Restless Legs Syndrome (RLS)
Clinical Trials
FDA Approved Products
Horizant
Manufacturer:Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Route:ORAL
Strength:600 mg in 1 1
Approved: 2022/08/31
NDC:53451-0101
Horizant
Manufacturer:Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Route:ORAL
Strength:300 mg in 1 1
Approved: 2022/08/31
NDC:53451-0103
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath